Meet the Company Using Artificial Intelligence for Designing Targeted Protein Degraders
Proteins are essential components of living matter – they function as building blocks for cells and tissues, as well as …
Biopharma Insights
7 Biotechs Fighting Rare Diseases With Gene-Editing Tech
As of now, only 5% of so-called rare diseases (orphan diseases) have an FDA-approved treatment available to patients. Rare diseases …
Choosing The Right CRO For Pharma R&D Outsourcing
This post was originally published on Quora, answering the question: "How do drug manufacturers select the right contract research organization(CRO)?" …
How Pharmaceutical Industry Is Adopting Artificial Intelligence To Boost Drug Research
What is “artificial intelligence”? Artificial intelligence (AI) is an interdisciplinary science concerned with building “intelligent agents”, the field which takes …
AI Helps Discover Potential First-in-class Molecule for Immuno-oncology for Fosun Pharma
The global artificial intelligence (AI) leader Insilico Medicine announced its first milestone in cancer immunotherapy for their external collaboration with …
Anticipated Drug Approvals 2022
Drug Discovery crystal ball gazing for the year ahead. And the hottest prospects are discussed below. We already have 5 …
Receptor.AI Tests an Innovative Technique of Chemical Data Augmentation for Discovering Anti-cancer Drugs
The BRD4 (Bromodomain-containing protein 4) protein is a transcriptional factor that plays an important role in cancer development. It has …
A New Player In Drug Discovery Promises to "Democratize" AI Solutions, Brings Flexibility
Artificial Intelligence (AI) in drug discovery is now on a steep rise. A growing number of companies compete to develop …
Are We Keeping Up With Antimicrobial Resistance?
Antimicrobial resistance (AMR) poses a major threat to human health. There were an estimated 4.95M deaths associated with bacterial AMR …
A March of “Big Tech” Corporations Into Pharmaceutical Industry
In November 2021, the parent company of Google, Alphabet, Inc., announced the launch of a new commercial subsidiary in the …
This Startup Proposes New Lightweight and Informative Molecular Descriptors for Drug Discovery
Over the last five or so years, the drug discovery industry has started adopting artificial intelligence (AI) at unprecedented scale, …
Bringing “Everything on Demand” to Longevity Industry
Deep Knowledge Group, a UK-based consortium of commercial and non-for-profit companies in the domain of longevity industry and deep tech …